New drug approvals, generic expansion, high-potency API demand, and the continued globalization of pharmaceutical manufacturing present lucrative business opportunities Small Molecule API ...
Opportunities center on HPAPIs for oncology and rare diseases, biotech APIs for biologics and biosimilars, AI-enabled continuous manufacturing, greener production, and localized, diversified supply ...